patients with lung or colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients: - Histologically confirmed diagnosis of: lung cancer (small cell * extensive disease/ stage III or IV, non-small cell stage III or IV) or colorectal cancer stage IV or metachronous metastases - written informed consent to participate - WHO performance status of 3 or under ;Carers: By participating patient identified as next of kin to be contacted by hospital staff if needed ;...
Exclusion criteria
Exclusion criteria: Patients: - Age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life (EORTC QLQ-C30; EORTC item bank EF short form), Symptoms (EORTC QLQ-C15 PAL) Qualitative study: patient experiences | — |
Secondary
| Measure | Time frame |
|---|---|
| Decisional quality (self constructed), Patient Activation (APECC), Satisfaction with care (EORTC IN-PATSAT32), Coping with their illness (COPE), Satisfaction with intervention (Patient Feedback Questionnaire), Socio demographic measures. Experiences of ospital care as reported by bereaved relatives (VOICES), anxiety and depression of bereaved relatives (HADS). Alignment of care as preferred (as indicated by the patient) with care as received (as measured in the medical files). | — |
Countries
Netherlands